Skip to content
EmergingResearch compound

DNP

Industrial chemical, not a medicine: tried as a fat burner, but it can cause fatal overheating and no amount is safe.

DNP vial

DETAILED OVERVIEW

What is DNP?

DNP (2,4-dinitrophenol) is an industrial chemical used to make dyes and explosives, not a medicine. In the 1930s it was briefly sold as a weight-loss drug in the United States, but its approval was withdrawn. Human use is banned in the European Union, including Hungary and Poland; importing it is illegal, and it is on the anti-doping list. Bodybuilders try to use it as a fat burner.

It uncouples energy production in the cells: most of the energy is released as heat instead of being used by the cell. The metabolism speeds up, but body temperature cannot be controlled, so fatal overheating and organ failure can develop. Most of the documented deaths happened in young, healthy men. There is no antidote, only cooling and intensive care. It leaves the body slowly, so fatal overheating can develop even a day or two after the last use. No amount is safe.

Mechanism

Mitochondrial uncoupler (ATP synthesis bypass)

Half-life

~36 hours (therapeutic dose, but cumulative)

Lethal dose

Acute: 4.3 mg/kg (~300 mg in adult)

Legal status

USA: FDA withdrew 1938. EU/HU: prohibited for human use. WADA: banned.

Data console

Lab data

Androgenic:Anabolic-
AR bindingN/A
Active half-life~36 h (cumulative)
Detection windowN/A
AromatizationNot applicable – industrial nitroaromatic compound (2,4-dinitrophenol mitochondrial uncoupler), NOT a steroid
HepatotoxicitySevere – multi-organ toxic; hyperthermia (>42°C), rhabdomyolysis, acute liver failure, MOF; fatalities reported independent of dose above 600 mg (Grundlingh 2011 PMID 21739343)

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Lethal, uncontrollable hyperthermia: body temperature can rise to 41–43°C with sweating, tachycardia and tachypnoea; documented fatal cases (Grundlingh 2011).
  • Profuse sweating and severe dehydration with electrolyte disturbances that further worsen the hyperthermia.
  • Tachycardia and tachypnoea (rapid heartbeat and breathing), restlessness and palpitations driven by the surge in metabolic load.
  • Rhabdomyolysis (muscle breakdown) that can lead to acute kidney failure.
  • Acute liver and multi-organ failure (MOF); high doses (>600 mg) can be fatal regardless of tolerance (Grundlingh 2011).
  • Confusion, agitation, seizures and coma due to hyperthermic central nervous system injury.
  • Cataracts and visual impairment, plus skin rash (dermatitis) with repeated exposure; yellow staining is characteristic.
  • Cumulative toxicity: with a ~36 h half-life, fatal hyperthermia can develop even 24–48 h AFTER the last dose. There is NO antidote, only ice cooling and intensive care.

Contraindications · 7

  • Any human (medical or weight-loss) use is absolutely contraindicated: withdrawn by the FDA in 1938, banned for human use in the EU, Hungary and Poland, prohibited by WADA. There is NO safe dose.
  • Hot or humid environments, physical exertion, sport and sauna: heat production and ambient heat add up, further raising the risk of fatal hyperthermia.
  • Concurrent thyroid hormones, stimulants (caffeine, ephedrine, clenbuterol, amphetamines) and any metabolism/heat-increasing agent: additive hyperthermia and cardiac strain.
  • Cardiovascular disease (arrhythmia, coronary disease, hypertension): the tachycardia and metabolic load can cause life-threatening cardiac decompensation.
  • Impaired kidney or liver function: slow clearance increases accumulation and the risk of multi-organ failure.
  • Pregnancy and breastfeeding: the compound is severely toxic with teratogenic potential and fetal hyperthermia risk; absolutely contraindicated.
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency: the nitroaromatic compound can trigger haemolysis and methaemoglobinaemia, worsening hypoxia and outcome.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about DNP?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.